Health Catalyst, Inc. (NASDAQ:HCAT) Receives Consensus Recommendation of "Hold" from Analysts

Key Points

• Health Catalyst has a consensus “Hold” rating from 11 analysts: seven holds, three buys and one sell. The average 12-month price target is $2.45, though several analysts recently lowered their targets.
• Institutional investors and hedge funds own approximately 85% of the company’s stock, with Palogic Value Management making a new $9.8 million investment during the second quarter.
• Shares opened at $1.69, while the company’s latest quarterly results exceeded expectations with revenue of $70.49 million and EPS of $0.04; however, Health Catalyst continues to report significant net losses and analysts expect negative full-year EPS.

Health Catalyst, Inc. (NASDAQ:HCAT - Get Free Report) has earned an average recommendation of "Hold" from the eleven research firms that are currently covering the company, Marketbeat reports. One equities research analyst has rated the stock with a sell recommendation, seven have assigned a hold recommendation and three have given a buy recommendation to the company. The average 1-year price objective among analysts that have covered the stock in the last year is $2.45.

A number of equities analysts have recently weighed in on the company. Cantor Fitzgerald reissued a "neutral" rating on shares of Health Catalyst in a report on Monday, May 11th. Weiss Ratings raised Health Catalyst from a "sell (e+)" rating to a "sell (d-)" rating in a research note on Tuesday, July 28th. Wells Fargo & Company dropped their price objective on Health Catalyst from $1.75 to $1.50 and set an "equal weight" rating for the company in a research report on Thursday, August 13th. Canaccord Genuity Group restated a "hold" rating and issued a $1.80 target price (down from $3.00) on shares of Health Catalyst in a report on Thursday, August 20th. Finally, Stephens reduced their target price on shares of Health Catalyst from $2.00 to $1.75 and set an "equal weight" rating on the stock in a report on Tuesday, May 12th.

Institutional Trading of Health Catalyst

A number of hedge funds have recently bought and sold shares of the company. Palogic Value Management L.P. purchased a new position in shares of Health Catalyst during the 2nd quarter worth $9,796,000. Hsbc Holdings PLC acquired a new stake in shares of Health Catalyst during the second quarter worth $809,000. HighMark Wealth Management LLC grew its position in shares of Health Catalyst by 139.0% in the fourth quarter. HighMark Wealth Management LLC now owns 741,482 shares of the company's stock valued at $1,772,000 after purchasing an additional 431,200 shares during the period. Bank of America Corp DE purchased a new stake in shares of Health Catalyst in the second quarter valued at $104,000. Finally, Deutsche Bank AG acquired a new position in Health Catalyst in the second quarter valued at $43,000. Institutional investors and hedge funds own 85.00% of the company's stock.

Health Catalyst Stock Down 1.2%

Shares of NASDAQ HCAT opened at $1.69 on Friday. The firm's 50-day moving average is $1.97 and its two-hundred day moving average is $1.64. The company has a market capitalization of $127.19 million, a PE ratio of -0.46 and a beta of 1.53. Health Catalyst has a 12-month low of $0.96 and a 12-month high of $3.62. The company has a debt-to-equity ratio of 1.51, a current ratio of 2.70 and a quick ratio of 2.70.

Health Catalyst (NASDAQ:HCAT - Get Free Report) last issued its quarterly earnings data on Thursday, August 6th. The company reported $0.04 earnings per share for the quarter, topping analysts' consensus estimates of $0.03 by $0.01. Health Catalyst had a negative net margin of 90.61% and a negative return on equity of 1.83%. The business had revenue of $70.49 million during the quarter, compared to analysts' expectations of $69.09 million. Equities analysts anticipate that Health Catalyst will post -0.18 EPS for the current fiscal year.

Health Catalyst Company Profile

Health Catalyst NASDAQ: HCAT is a healthcare data and analytics technology company founded in 2008 and headquartered in Salt Lake City, Utah. The company went public in 2019 and has since focused on delivering a unified data platform that helps healthcare organizations aggregate and analyze clinical, financial and operational information.

The core of Health Catalyst's offering is the Data Operating System (DOS), a modular data management platform that integrates disparate data sources—from electronic health records to claims and patient-generated data—into a single analytics environment.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source